{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:37:02Z","timestamp":1790044622035,"version":"4.0.1"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Control of cytomegalovirus (CMV) infection after solid organ transplantation (SOT) requires a functional immune system. We assessed the association between quantitation and function of CMV-specific CD8+ T cells and CMV infection in SOT recipients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>During a 10-year period, selected kidney, heart, lung, pancreas, liver, and composite tissue recipients were tested for CMV-specific CD8+ T cells immune competence (CMV-CD8+), as measured by enumeration, interferon-gamma production, and CD107a\/b degranulation. Quantitative and functional data were used to assemble T-cell immune competence (TIC) score. CMV infection was diagnosed by polymerase chain reaction in blood and other samples or histopathology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      Of 130 patients tested, 59 had CMV infection or disease. The median onset to CMV infection was 10.5 months (interquartile range [IQR], 5.5\u201318.7). Gastrointestinal disease (28.8%), pneumonia (20.3%), and CMV syndrome (17%) were most common presentation. An impaired nonspecific or CMV-CD8+ TIC score was associated with tissue-invasive disease (hazard risk, 2.84, 95% confidence interval, 1.03\u201311.81;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.04). Patients with impaired CMV-CD8+ TIC score had longer viremia duration (42.4 days vs 18.8 d;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Patients with impaired nonspecific or CMV-CD8+ TIC score had higher risk of relapse (68.8% vs 27.9%; hazard risk, 2.56; 95% confidence interval, 1.09\u20135.89;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.03). Patients with CMV infection or disease had lower median absolute lymphocyte count (380 [IQR, 240\u2013540] vs 940 [IQR, 551\u20131210] cells\/mm\n                      <jats:sup>3<\/jats:sup>\n                      ;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001) and CD4+ T cell count (29 cells\/mm\n                      <jats:sup>3<\/jats:sup>\n                      [IQR, 1.3\u2013116.0] vs 325.5 cells\/mm\n                      <jats:sup>3<\/jats:sup>\n                      [IQR, 151.5\u2013589.8];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Nonspecific and CMV-specific CD8+ T-cell function correlated with the course of CMV after SOT, and measuring these has the potential to assist in its clinical management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000002396","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T16:46:16Z","timestamp":1533660376000},"page":"832-838","source":"Crossref","is-referenced-by-count":47,"title":["Clinical Correlation of Cytomegalovirus Infection With CMV-specific CD8+ T-cell Immune Competence Score and Lymphocyte Subsets in Solid Organ Transplant Recipients"],"prefix":"10.1097","volume":"103","author":[{"given":"Atibordee","family":"Meesing","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN."},{"name":"Division of Infectious Disease and Tropical Medicine, Department of Medicine, Khon Kaen University, Khonkean, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshini S.","family":"Abraham","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymund R.","family":"Razonable","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN."},{"name":"William J von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1186\/s12879-017-2599-y","article-title":"Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience.","volume":"17","author":"Selvey","year":"2017","journal-title":"BMC Infect Dis"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/jmv.23539","article-title":"High risk of cytomegalovirus infection following solid organ transplantation despite prophylactic therapy.","volume":"85","author":"Harvala","year":"2013","journal-title":"J Med Virol"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.hemonc.2017.05.001","article-title":"Emerging concepts in cytomegalovirus infection following hematopoietic stem cell transplantation.","volume":"10","author":"Camargo","year":"2017","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nri.2016.38","article-title":"T cell responses to cytomegalovirus.","volume":"16","author":"Klenerman","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4110\/in.2015.15.4.186","article-title":"Cytomegalovirus infection and memory T cell inflation.","volume":"15","author":"Kim","year":"2015","journal-title":"Immune Netw"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1172\/JCI90599","article-title":"Immunotherapy for transplantation-associated viral infections.","volume":"127","author":"Roddie","year":"2017","journal-title":"J Clin Invest"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/146532402317251473","article-title":"Adoptive transfer of Ag-specific T cells to prevent CMV disease after allogeneic stem-cell transplantation.","volume":"4","author":"van Rhee","year":"2002","journal-title":"Cytotherapy"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/MOT.0b013e32834016b9","article-title":"T-cell therapy for cytomegalovirus infection.","volume":"15","author":"Mui","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1182\/blood-2008-05-157354","article-title":"Human NK cells can control CMV infection in the absence of T cells.","volume":"112","author":"Kuijpers","year":"2008","journal-title":"Blood"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-4939-0928-5_20","article-title":"Intracellular staining and detection of cytokines by fluorescence-activated flow cytometry.","volume":"1172","author":"Freer","year":"2014","journal-title":"Methods Mol Biol"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/ctr.12516","article-title":"Epidemiology of invasive fungal infections in lung transplant recipients on long-term azole antifungal prophylaxis.","volume":"29","author":"Chong","year":"2015","journal-title":"Clin Transplant"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1399-0012.2009.01076.x","article-title":"The impact of invasive fungal diseases on survival after lung transplantation.","volume":"24","author":"Arthurs","year":"2010","journal-title":"Clin Transplant"},{"issue":"Suppl 4)","key":"R13-20231002","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ajt.12103","article-title":"AST Infectious Diseases Community of Practice. Cytomegalovirus in solid organ transplantation.","volume":"13","author":"Razonable","year":"2013","journal-title":"Am J Transplant"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/cid\/cit096","article-title":"Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in transplant recipients.","volume":"56","author":"Razonable","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials.","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects.","volume":"202","author":"Sylwester","year":"2005","journal-title":"J Exp Med"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1182\/blood-2002-11-3472","article-title":"Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation.","volume":"102","author":"Hakki","year":"2003","journal-title":"Blood"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.clim.2005.12.001","article-title":"Distinct patterns of regeneration of central memory, effector memory and effector TCD8+ cell subsets after different hematopoietic cell transplant types: possible influence in the recovery of anti-cytomegalovirus immune response and risk for its reactivation.","volume":"119","author":"Ferrari","year":"2006","journal-title":"Clin Immunol"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1086\/428136","article-title":"Simultaneous reconstitution of multiple cytomegalovirus-specific CD8+ cell populations with divergent functionality in hematopoietic stem-cell transplant recipients.","volume":"191","author":"Lacey","year":"2005","journal-title":"J Infect Dis"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4254\/wjh.v6.i6.370","article-title":"Management of cytomegalovirus infection and disease in liver transplant recipients.","volume":"6","author":"Bruminhent","year":"2014","journal-title":"World J Hepatol"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/TP.0b013e318238dab3","article-title":"Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial.","volume":"93","author":"Witzke","year":"2012","journal-title":"Transplantation"},{"key":"R22-20231002","first-page":"Cd005133","article-title":"Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.","author":"Owers","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R23-20231002","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.trre.2014.01.001","article-title":"The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients.","volume":"28","author":"Roman","year":"2014","journal-title":"Transplant Rev (Orlando)"},{"key":"R24-20231002","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/cid\/cis818","article-title":"State-of-the-art monitoring of cytomegalovirus-specific cell-mediated immunity after organ transplant: a primer for the clinician.","volume":"55","author":"Egli","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R25-20231002","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/tid.12417","article-title":"Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+\/R\u2212 solid organ transplant recipients.","volume":"17","author":"San-Juan","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"R26-20231002","doi-asserted-by":"crossref","first-page":"e0189488","DOI":"10.1371\/journal.pone.0189488","article-title":"Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients.","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS ONE"},{"key":"R27-20231002","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1432-2277.2009.01017.x","article-title":"A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection.","volume":"23","author":"Eid","year":"2010","journal-title":"Transpl Int"},{"key":"R28-20231002","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1111\/ajt.14347","article-title":"An interventional study using cell-mediated immunity to personalize therapy for cytomegalovirus infection after transplantation.","volume":"17","author":"Kumar","year":"2017","journal-title":"Am J Transplant"},{"key":"R29-20231002","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1600-6143.2009.02618.x","article-title":"Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients.","volume":"9","author":"Kumar","year":"2009","journal-title":"Am J Transplant"},{"key":"R30-20231002","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/cid\/cis993","article-title":"Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study.","volume":"56","author":"Manuel","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R31-20231002","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/j.1600-6143.2005.00871.x","article-title":"Differences in CMV-specific T-cell levels and long-term susceptibility to CMV infection after kidney, heart and lung transplantation.","volume":"5","author":"Sester","year":"2005","journal-title":"Am J Transplant"},{"key":"R32-20231002","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/lt.23991","article-title":"Pretransplant lymphopenia is a novel prognostic factor in cytomegalovirus and noncytomegalovirus invasive infections after liver transplantation.","volume":"20","author":"Nierenberg","year":"2014","journal-title":"Liver Transpl"},{"issue":"Suppl 1","key":"R33-20231002","doi-asserted-by":"crossref","first-page":"S733","DOI":"10.1093\/ofid\/ofx163.1975","article-title":"Lymphopenia: a novel predictor for recurrent cytomegalovirus disease in solid organ transplant recipients.","volume":"4","author":"Gardiner","year":"2017","journal-title":"Open Forum Infect Diseas"},{"key":"R34-20231002","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1073\/pnas.1117194109","article-title":"Polyfunctional responses by human T cells result from sequential release of cytokines.","volume":"109","author":"Han","year":"2012","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007890-201904000-00035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:53:15Z","timestamp":1786038795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-201904000-00035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002396","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}